Your session is about to expire
← Back to Search
HM15912 for Short Bowel Syndrome
Study Summary
This trial will test a new drug for safety, how it is processed by the body, and how it affects people with a specific intestinal disorder.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have been cancer-free for 5 years, except for certain skin or cervical cancers.I am an adult with Short Bowel Syndrome causing intestinal failure.I have short bowel syndrome, no recent surgeries, and stable IV nutrition needs.I have had colon cancer in the past.
- Group 1: HM15912 0.5 mg/kg, 1.0mg/kg, 1.5mg/kg Active
- Group 2: Matching Placebo
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are patients still being accepted for this experiment?
"That is correct, the online information does show that this study is still recruiting individuals. The original posting date was March 3rd, 2022 with the most recent edit on November 3rd of the same year. There are 5 locations where a total of 18 patients will be enrolled."
What is the standing of HM15912 with the FDA?
"The safety of HM15912 Active is a 2. This is because, although there is supporting data for its safety, none of it speaks to the efficacy of the medication."
Are there many places in the US where this research is taking place?
"Presently, this study is looking for individuals to enroll from 5 sites. 3 of these locations are in New york, Atlanta and Columbia with the other 2 still yet to be determined. If you are considering participating, try and select a location close to reduce travel time commitments."
Is there a limit to the amount of people who can join this trial?
"According to the information on clinicaltrials.gov, this trial is recruiting patients as we speak. The posting date was March 3rd, 2022 and it has been updated November 3rd, 2022. They are looking for 18 individuals total from 5 separate locations."
Share this study with friends
Copy Link
Messenger